Literature DB >> 24900699

Tricyclic Pyrimidines As Inhibitors of DYRK1A/DYRK1B As Potential Treatment for Down's Syndrome or Alzheimer's Disease.

Gerard Rosse1.   

Abstract

Entities:  

Year:  2013        PMID： 24900699      PMCID： PMC4027564          DOI： 10.1021/ml400137s

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

1.  Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part II.

Authors:  Alicia Foucourt; Damien Hédou; Carole Dubouilh-Benard; Angélique Girard; Thierry Taverne; Anne-Sophie Casagrande; Laurent Désiré; Bertrand Leblond; Thierry Besson
Journal:  Molecules       Date:  2014-09-26       Impact factor: 4.411

2.  Sulfur-containing therapeutics in the treatment of Alzheimer's disease.

Authors:  Haizhou Zhu; Venkateshwara Dronamraju; Wei Xie; Swati S More
Journal:  Med Chem Res       Date:  2021-01-15       Impact factor: 1.965

3.  Naturally Inspired Pyrimidines Analogues for Alzheimer's Disease.

Authors:  Shivani Singh; Meenakshi Dhanawat; Sumeet Gupta; Deepak Kumar; Saloni Kakkar; Anroop Nair; Inderjeet Verma; Prerna Sharma
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.